Adiumentum Capital Fund I Lp Atara Biotherapeutics, Inc. (ATRA) insider trading activity

ATRA Quotes by TradingView

Adiumentum Capital Fund I LP is Director of Atara Biotherapeutics, Inc.. Currently has a direct ownership of 1.21 Million shares of ATRA, which is worth approximately $13.9 Million. The most recent transaction as insider was on May 16, 2025, when has been sold 75,572 shares (Common Stock) at a price of $6.61 per share, resulting in proceeds of $499,530. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.21M
n/a 3M change
n/a 12M change
Total Value Held $13.9 Million

Adiumentum Capital Fund I LP Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 16 2025
BUY
Grant, award, or other acquisition
$499,530 $6.61 p/Share
75,572 Added 5.88%
1,209,395 Common Stock
ACF

Adiumentum Capital Fund I LP

Director
Boston, MA

Track Institutional and Insider Activities on ATRA

Follow Atara Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATRA shares.

Notify only if

Insider Trading

Get notified when an Atara Biotherapeutics, Inc. insider buys or sells ATRA shares.

Notify only if

News

Receive news related to Atara Biotherapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ATRA